NSE · ANTHEM.NS
Anthem Biosciences Ltd.
₹825.60-₹4.55 (-0.55%)
Anthem Biosciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.54% below the high.
Loading market information…
NSE · HALEOSLABS.NS · INR
Stock price, dividends
Quote as of Oct 30, 2026, 08:07 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Haleos Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 22.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Haleos Labs Limited’s forward annual dividend is ₹1.50 per share, paid annual. The forward yield is 0.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Haleos Labs Limited, an Indian-based pharmaceutical enterprise, specializes in the production of crucial active pharmaceutical ingredients (APIs) and intermediate compounds. Their extensive portfolio encompasses a wide array of therapeutic applications, providing treatments for conditions such as ulcers, migraines, hypertension, and erectile dysfunction. Additionally, the company develops products for cancer, fungal infections, obesity, nausea, depression, parasitic infestations, various infectious diseases, gout, convulsions, viral ailments, and anesthesia. They also supply ingredients for antihistamines, diuretics, hair loss treatments, and ophthalmic preparations. A significant portion of their manufactured goods is destined for international markets. Established in 1990 and headquartered in Hyderabad, India, the firm was formerly known as SMS Lifesciences India Limited and is scheduled to officially adopt its current name, Haleos Labs Limited, in August 2025.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹825.60-₹4.55 (-0.55%)
Anthem Biosciences Ltd.’s quoted price sits in the upper half of its reported 52-week range, 15.54% below the high.
₹506.75+₹3.20 (+0.64%)
Blue Jet Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 26.35% below the high.
₹847.15-₹22.15 (-2.55%)
Supriya Lifescience Limited’s quoted price sits in the upper half of its reported 52-week range, 21.92% below the high.
₹517.40+₹31.60 (+6.5%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.58% below the high.
₹2,649.10-₹354.70 (-11.81%)
RPG Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 15.3% below the high.
₹146.27-₹3.15 (-2.11%)
Dishman Carbogen Amcis Limited’s quoted price sits in the lower half of its reported 52-week range, 51.73% below the high.
₹2,287.00-₹20.60 (-0.89%)
Hester Biosciences Limited’s quoted price sits in the upper half of its reported 52-week range, 14.78% below the high.
₹316.60-₹9.30 (-2.85%)
Panacea Biotec Limited’s quoted price sits in the lower half of its reported 52-week range, 51.07% below the high.
